摘要
目的:观察思连康联合思密达治疗婴儿迁延性腹泻病的疗效。方法:将98例迁延性腹泻患儿随机分为两组,对照组48例给予思密达治疗,治疗组50例在此基础上加用思连康治疗。结果:经过治疗后,治疗组的有效率86.0%,明显高于对照组56.2%,两组间有极显著性差异(X2=10.66,P<0.01)。结论:思连康联合思密达是治疗婴儿迁延性腹泻病的有效方法。
Objective：To observe Si Liankang combined with Smecta in treatment of infant deferred diarrhea patients.Methods：98 patients with protracted diarrhea were randomly divided into two groups,48 cases in the control group,giving Smecta treatment,50 cases in the treatment group were added in silico treatment.Results：after treatment,the treatment group efficiency（86%）,significantly higher than that in control group（56.2%）,between the two groups had significant difference（X2=10.66,P0.01）.Conclusion：Si Liankang and Smecta in treatment of infant deferred diarrhea disease is effective method.
关键词
思连康
思密达
婴儿
迁延性腹泻
Si Liankang
Smectite
Baby
Persisting diarrhea
